NO2994485T3 - - Google Patents

Info

Publication number
NO2994485T3
NO2994485T3 NO14722194A NO14722194A NO2994485T3 NO 2994485 T3 NO2994485 T3 NO 2994485T3 NO 14722194 A NO14722194 A NO 14722194A NO 14722194 A NO14722194 A NO 14722194A NO 2994485 T3 NO2994485 T3 NO 2994485T3
Authority
NO
Norway
Application number
NO14722194A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO2994485T3 publication Critical patent/NO2994485T3/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065Purification, fragmentation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/36Extraction; Separation; Purification by a combination of two or more processes of different types
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/12Purification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Sustainable Development (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Water Supply & Treatment (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
NO14722194A 2013-05-06 2014-05-06 NO2994485T3 (enEXAMPLES)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13305593 2013-05-06
EP14722194.9A EP2994485B1 (en) 2013-05-06 2014-05-06 Continuous multistep process for purifying antibodies
PCT/EP2014/059246 WO2014180852A1 (en) 2013-05-06 2014-05-06 Continuous multistep process for purifying antibodies

Publications (1)

Publication Number Publication Date
NO2994485T3 true NO2994485T3 (enEXAMPLES) 2018-06-09

Family

ID=48430636

Family Applications (1)

Application Number Title Priority Date Filing Date
NO14722194A NO2994485T3 (enEXAMPLES) 2013-05-06 2014-05-06

Country Status (19)

Country Link
US (1) US10793622B2 (enEXAMPLES)
EP (2) EP3301115B1 (enEXAMPLES)
JP (2) JP6463734B2 (enEXAMPLES)
KR (1) KR102272851B1 (enEXAMPLES)
CN (2) CN105358572A (enEXAMPLES)
AU (1) AU2014264697B2 (enEXAMPLES)
BR (1) BR112015027812B1 (enEXAMPLES)
CA (1) CA2911462C (enEXAMPLES)
CY (1) CY1125281T1 (enEXAMPLES)
DK (2) DK2994485T3 (enEXAMPLES)
ES (2) ES2665645T3 (enEXAMPLES)
HU (2) HUE038741T2 (enEXAMPLES)
IL (1) IL242408B (enEXAMPLES)
MX (1) MX368177B (enEXAMPLES)
NO (1) NO2994485T3 (enEXAMPLES)
RU (1) RU2662668C2 (enEXAMPLES)
SG (1) SG11201508968XA (enEXAMPLES)
TW (2) TWI631132B (enEXAMPLES)
WO (1) WO2014180852A1 (enEXAMPLES)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9458450B2 (en) 2012-03-15 2016-10-04 Flodesign Sonics, Inc. Acoustophoretic separation technology using multi-dimensional standing waves
US9950282B2 (en) 2012-03-15 2018-04-24 Flodesign Sonics, Inc. Electronic configuration and control for acoustic standing wave generation
US10704021B2 (en) 2012-03-15 2020-07-07 Flodesign Sonics, Inc. Acoustic perfusion devices
US10967298B2 (en) 2012-03-15 2021-04-06 Flodesign Sonics, Inc. Driver and control for variable impedence load
WO2014066471A1 (en) * 2012-10-24 2014-05-01 Genzyme Corporation Elution of biomolecules from multi-modal resins using mes and mops as mobile phase modifiers
JPWO2015041218A1 (ja) * 2013-09-17 2017-03-02 株式会社カネカ 新規抗体精製方法及びそれから得られる抗体(NovelAntibodyPurificationMethodandAntibodyobtainedtherefrom)、並びに陽イオン交換基を用いた新規抗体精製法及びそれから得られる抗体(NovelAntibodyPurificationmethodusingCationExchangerandAntibodyobtainedtherefrom)
CN105939767B (zh) 2014-01-08 2018-04-06 弗洛设计声能学公司 具有双声电泳腔的声电泳装置
GB201503578D0 (en) * 2015-03-03 2015-04-15 Ge Healthcare Bio Sciences Ab Sanitization method for affinity chromatography matrices
US11377651B2 (en) 2016-10-19 2022-07-05 Flodesign Sonics, Inc. Cell therapy processes utilizing acoustophoresis
US11021699B2 (en) 2015-04-29 2021-06-01 FioDesign Sonics, Inc. Separation using angled acoustic waves
US11708572B2 (en) 2015-04-29 2023-07-25 Flodesign Sonics, Inc. Acoustic cell separation techniques and processes
EP3015542A1 (de) * 2015-05-07 2016-05-04 Bayer Technology Services GmbH Modulare anlage und verfahren zur kontinuierlichen, keimreduzierten produktion und/oder aufbereitung eines produktes
US11459540B2 (en) 2015-07-28 2022-10-04 Flodesign Sonics, Inc. Expanded bed affinity selection
US11474085B2 (en) 2015-07-28 2022-10-18 Flodesign Sonics, Inc. Expanded bed affinity selection
US20170101437A1 (en) * 2015-10-09 2017-04-13 Hetero Drugs Ltd. Process for purification of darbepoetin alfa
US11085035B2 (en) 2016-05-03 2021-08-10 Flodesign Sonics, Inc. Therapeutic cell washing, concentration, and separation utilizing acoustophoresis
US11214789B2 (en) 2016-05-03 2022-01-04 Flodesign Sonics, Inc. Concentration and washing of particles with acoustics
US20190211055A1 (en) * 2016-09-14 2019-07-11 Kinbio Ltd. Methods of purifying and qualifying antibodies
JP2020513248A (ja) 2016-10-19 2020-05-14 フロデザイン ソニックス, インク.Flodesign Sonics, Inc. 音響による親和性細胞抽出
CA3057286A1 (en) * 2017-03-24 2018-09-27 Council Of Scientific And Industrial Research A process for the purification of recombinant antibody fragments
GB201711481D0 (en) * 2017-07-17 2017-08-30 Ucb Biopharma Sprl Protein purification
WO2019045149A1 (en) * 2017-08-31 2019-03-07 Green Cross Corporation PROCESS FOR PURIFYING SULFATASE PROTEIN
CA3085784A1 (en) 2017-12-14 2019-06-20 Flodesign Sonics, Inc. Acoustic transducer driver and controller
CN119881293A (zh) 2018-03-21 2025-04-25 沃特世科技公司 基于非抗体高亲和力的样品制备、吸附剂、装置和方法
EP3546475A1 (en) * 2018-03-27 2019-10-02 Sanofi Full flow-through process for purifying recombinant proteins
US12071607B2 (en) * 2018-06-01 2024-08-27 Lonza Ltd. Midscale model for organic growth and phasing
KR102337683B1 (ko) 2018-09-21 2021-12-13 주식회사 녹십자 고효율 항-tfpi 항체 조성물
EP3636657A1 (en) * 2018-10-08 2020-04-15 Ablynx N.V. Chromatography-free antibody purification method
WO2020084503A1 (en) * 2018-10-26 2020-04-30 Cadila Healthcare Limited A composition comprising antibody with reduced level of basic variants thereof
WO2020183332A1 (en) * 2019-03-11 2020-09-17 Intas Pharmaceuticals Ltd. Purification of adalimumab using tandem chromatography
WO2020205928A1 (en) * 2019-04-03 2020-10-08 Genzyme Corporation Continuous production of recombinant proteins
CN114026108B (zh) * 2019-06-28 2024-09-10 夏尔巴生物技术(苏州)有限公司 无缝连续流层析方法
KR102154952B1 (ko) * 2020-02-21 2020-09-10 프레스티지바이오로직스 주식회사 아달리무맙의 Non-Protein A 정제방법
CN112574321B (zh) * 2020-12-30 2023-10-20 上海赛金生物医药有限公司 一种捕获单克隆抗体-肿瘤坏死因子融合蛋白的亲和纯化方法
WO2022234412A1 (en) 2021-05-03 2022-11-10 Lupin Limited A process for purification of fc-fusion proteins

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU626008B2 (en) 1987-10-23 1992-07-23 Schering Corporation Method of purifying protein
ATE175975T1 (de) * 1993-09-21 1999-02-15 Hemosol Inc Verdrängungschromatographisches verfahren und gereinigtes hämoglobin
CA2106612C (en) 1993-09-21 2001-02-06 Diana Pliura Displacement chromatography process
US5891741A (en) 1997-05-16 1999-04-06 Coulter International Corp. Antibody-aminodextran-phycobiliprotein conjugates
CN1136317C (zh) 1999-03-12 2004-01-28 中国人民解放军第四军医大学 单克隆抗体双段和单段的制备方法
US20020009445A1 (en) 2000-07-12 2002-01-24 Yansheng Du Human beta-amyloid antibody and use thereof for treatment of alzheimer's disease
US6602855B2 (en) 2001-04-30 2003-08-05 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1449 daltons
CN1504482A (zh) * 2002-12-03 2004-06-16 北京优力凯生物技术有限责任公司 无细胞百日咳抗原蛋白的分离纯化方法
ES2738112T3 (es) 2004-04-21 2020-01-20 Brigham & Womens Hospital Inc Péptidos de fijación a la poli-N-acetil glucosamina (PNAG/dPNAG) y procedimientos para el uso de los mismos
CA2583578C (en) * 2004-10-21 2014-04-01 Ge Healthcare Bio-Sciences Ab Chromatography ligand
NZ586780A (en) 2005-03-23 2012-02-24 Genmab As Antibodies against CD38 for treatment of multiple myeloma
CN1814775A (zh) 2005-12-06 2006-08-09 中国海洋大学 一种抗病毒活性寡聚肽的制备方法
EP1914242A1 (en) * 2006-10-19 2008-04-23 Sanofi-Aventis Novel anti-CD38 antibodies for the treatment of cancer
KR101293504B1 (ko) * 2007-07-11 2013-08-07 노보 노르디스크 에이/에스 혼합형 또는 다중형 수지를 사용하는 인자 vⅰⅰⅰ의 정제
US8470321B2 (en) 2007-11-16 2013-06-25 The Rockefeller University Antibodies specific for the protofibril form of beta-amyloid protein
TWI472339B (zh) * 2008-01-30 2015-02-11 Genentech Inc 包含結合至her2結構域ii之抗體及其酸性變異體的組合物
AU2009222115A1 (en) * 2008-02-29 2009-09-11 Biogen Idec Ma Inc. Purified immunoglobulin fusion proteins and methods of their purification
CN103396480A (zh) 2008-05-15 2013-11-20 诺沃—诺迪斯克有限公司 抗体纯化方法
MX2011000666A (es) * 2008-07-18 2011-03-21 Talecris Biotherapeutics Inc Metodo para preparar inhibidor de alfa-1 proteinasa.
EP2360183B1 (en) 2008-12-19 2016-07-27 Takeda Pharmaceutical Company Limited Antibody purification method by mixed mode chromatography utilizing an arginine-containing loading solution
CN102272146A (zh) 2009-01-13 2011-12-07 通用电气健康护理生物科学股份公司 用带负电的聚合物沉淀生物分子
KR101224468B1 (ko) * 2009-05-20 2013-01-23 주식회사 파멥신 신규한 형태의 이중표적항체 및 그 용도
WO2011017514A1 (en) * 2009-08-07 2011-02-10 Millipore Corporation Methods for purifying a target protein from one or more impurities in a sample
US9527010B2 (en) * 2009-09-25 2016-12-27 Ge Healthcare Bio-Sciences Corp. Separation system and method
WO2011049798A1 (en) * 2009-10-20 2011-04-28 Merck Sharp & Dohme Corp. Use of mixed mode chromatography for the capture and purification of basic antibody products
EP2695889A1 (en) 2009-12-29 2014-02-12 Dr. Reddy's Laboratories Limited Protein purification by ion exchange
ES2534936T3 (es) 2010-08-02 2015-04-30 Ratiopharm Gmbh Método para producir y purificar una sialiltransferasa soluble activa
WO2012125735A1 (en) * 2011-03-15 2012-09-20 Abott Laboratories An integrated approach to the isolation and purification of antibodies
AU2012236486B2 (en) 2011-03-29 2016-06-23 Glaxosmithkline Llc Buffer system for protein purification
JP6121409B2 (ja) 2011-06-17 2017-04-26 ロッシュ ダイアグノスティクス ヘマトロジー インコーポレイテッド 生体試料の組織処理のための溶液
WO2013028330A2 (en) 2011-08-19 2013-02-28 Emd Millipore Corporation Methods of reducing level of one of more impurities in a sample during protein purification
EP2578286A1 (en) * 2011-10-04 2013-04-10 Merck Patent GmbH Method and apparatus for chromatographic purification
SG11201401360XA (en) * 2011-10-25 2014-05-29 Onclave Therapeutics Ltd Antibody formulations and methods
WO2013075740A1 (en) 2011-11-23 2013-05-30 Sanofi Antibody purification method

Also Published As

Publication number Publication date
MX368177B (es) 2019-09-23
ES2905675T3 (es) 2022-04-11
IL242408B (en) 2020-04-30
CA2911462A1 (en) 2014-11-13
EP3301115A1 (en) 2018-04-04
KR20160005047A (ko) 2016-01-13
TWI631132B (zh) 2018-08-01
BR112015027812A2 (pt) 2017-07-25
MX2015015482A (es) 2016-03-21
US20160083454A1 (en) 2016-03-24
AU2014264697B2 (en) 2019-08-22
JP2019104735A (ja) 2019-06-27
ES2665645T3 (es) 2018-04-26
DK3301115T3 (da) 2022-01-31
HUE057119T2 (hu) 2022-04-28
EP2994485A1 (en) 2016-03-16
KR102272851B1 (ko) 2021-07-02
RU2015151869A (ru) 2017-06-13
CA2911462C (en) 2021-04-06
DK2994485T3 (en) 2018-04-23
EP3301115B1 (en) 2021-11-10
BR112015027812B1 (pt) 2021-03-30
CN116003579A (zh) 2023-04-25
SG11201508968XA (en) 2015-11-27
JP2016519137A (ja) 2016-06-30
US10793622B2 (en) 2020-10-06
HUE038741T2 (hu) 2018-11-28
CN105358572A (zh) 2016-02-24
TW201908331A (zh) 2019-03-01
CY1125281T1 (el) 2023-06-09
EP2994485B1 (en) 2018-01-10
TWI675041B (zh) 2019-10-21
JP6463734B2 (ja) 2019-02-06
RU2662668C2 (ru) 2018-07-26
WO2014180852A1 (en) 2014-11-13
AU2014264697A1 (en) 2015-11-26
TW201522363A (zh) 2015-06-16

Similar Documents

Publication Publication Date Title
AP2016009275A0 (enEXAMPLES)
BR102016010778A2 (enEXAMPLES)
BR112015007533A2 (enEXAMPLES)
BR112014017733A2 (enEXAMPLES)
BR112014018502A2 (enEXAMPLES)
BR112014017739A2 (enEXAMPLES)
BR112014019326A2 (enEXAMPLES)
BR112014018516A2 (enEXAMPLES)
BR112014017855A2 (enEXAMPLES)
BR112014018480A2 (enEXAMPLES)
BR112014020341A2 (enEXAMPLES)
BR112014017765A2 (enEXAMPLES)
BR112014017669A2 (enEXAMPLES)
BR112014021878A2 (enEXAMPLES)
BR112014018468A2 (enEXAMPLES)
BR112014017901A2 (enEXAMPLES)
BR112014019204A2 (enEXAMPLES)
BR112014018207A2 (enEXAMPLES)
BR112014017722A2 (enEXAMPLES)
BR112014017653A2 (enEXAMPLES)
BR112014018578A2 (enEXAMPLES)
BR112014018483A2 (enEXAMPLES)
BR112014017794A2 (enEXAMPLES)
BR112014017601A2 (enEXAMPLES)
BR112015015312A2 (enEXAMPLES)